These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30762768)

  • 21. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editor's Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial.
    Karlsson S; Andell P; Mohammad MA; Koul S; Olivecrona GK; James SK; Fröbert O; Erlinge D
    Eur Heart J Acute Cardiovasc Care; 2019 Feb; 8(1):15-23. PubMed ID: 28862032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
    Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
    Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
    Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
    Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention.
    Pi SF; Liu YW; Li T; Wang Y; Zhou Q; Liu BJ; Peng WJ; Li X; Wang YY; Huang L
    J Thorac Dis; 2019 Mar; 11(3):744-752. PubMed ID: 31019762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention.
    Gao MD; Zhang EY; Liu YY; Li XW; Xiao JY; Sun GY; Liu Y
    Chin Med J (Engl); 2020 Apr; 133(7):766-772. PubMed ID: 32149760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Deferred versus immediate stenting in patients with ST - segment elevation myocardial infarction and residual large thrombus burden reclassified in the culprit lesion].
    Custodio-Sánchez P; Damas-De Los Santos F; Peña-Duque MA; Coutiño-Castelán D; Arias-Sánchez E; Abundes-Velasco A; Castro-Alvarado O; Colon-Arias FA; Alvarenga-Fajardo C; Hernández-Fonseca C; Rodríguez-Barriga E; Hernández-Padilla A
    Arch Cardiol Mex; 2018 Dec; 88(5):432-440. PubMed ID: 29706554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.
    Ma M; Wang L; Diao KY; Liang SC; Zhu Y; Wang H; Wang M; Zhang L; Yang ZG; He Y
    BMC Cardiovasc Disord; 2022 Feb; 22(1):30. PubMed ID: 35120436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials.
    Shi L; Chen L; Qi G; Tian W; Zhao S
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):191-198. PubMed ID: 31423544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI).
    Gao L; Cao Z; Zhang H
    Med Sci Monit; 2016 Jul; 22():2699-705. PubMed ID: 27475844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between visible thrombus aspiration material with no-reflow and in-hospital mortality ratio in patients with anterior ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Şeker T; Türkoğlu C; Akkuş O; Gür M
    Turk Kardiyol Dern Ars; 2019 Mar; 47(2):95-102. PubMed ID: 30874511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Wang Z; Liu N; Ren L; Lei L; Ye H; Peng J
    Arq Bras Cardiol; 2018 Apr; 110(4):333-338. PubMed ID: 29538502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.
    Kumar R; Khan KA; Shah JA; Ammar A; Kumar D; Khowaja S; Sial JA; Kazmi S; Murtaza M; Karim M
    J Ayub Med Coll Abbottabad; 2022; 34(2):288-294. PubMed ID: 35576288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of thrombus aspiration during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction].
    Shen C; Wang LF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):49-55. PubMed ID: 30669810
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterogeneity of the No-Reflow Group After Primary Percutaneous Coronary Intervention Due to ST-Segment Elevation Myocardial Infarction - Are There Sex Differences?
    Zachura M; Sadowski M; Kurzawski J; Piątek K; Gąsior M
    Cardiovasc Revasc Med; 2022 Apr; 37():97-101. PubMed ID: 34167912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.